Key result
NTC-801 dose-dependently decreased AF inducibility and prolonged atrial ERP more effectively than dofetilide and flecainide in a canine model of atrial tachypacing.
Why the study?
Does NTC-801 reduce AF inducibility and terminate AF in a canine model of atrial tachypacing compared to dofetilide and flecainide?
Does NTC-801 reduce AF inducibility and terminate AF in a canine model of atrial tachypacing compared to dofetilide and flecainide?
NTC-801, a selective KACh channel blocker, effectively prevents and terminates atrial fibrillation in a canine model of electrical remodeling, outperforming dofetilide and flecainide.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications from this animal model; leaves open translation of selective KACh blockade to human AF.
The present study examines the effects of NTC-801, a highly selective acetylcholine (ACh) receptor-activated potassium (KACh) channel blocker, on atrial fibrillation (AF) in a canine model with electrical remodeling. An experimental substrate for AF was created in dogs via left atrial (LA) tachypacing (400 bpm, 3-5 weeks). NTC-801, dofetilide, and flecainide were intravenously infused for 15 minutes, and the effects on AF inducibility, atrial effective refractory period (ERP), and atrial conduction velocity were examined. The effect of NTC-801 on AF termination was also evaluated. Atrial ERP was shortened and AF inducibility was increased after LA tachypacing. NTC-801 (0.3-3 µg·kg⁻¹·min⁻¹) prolonged atrial ERP irrespective of stimulation frequency and dose-dependently decreased AF inducibility. Dofetilide (5.3 µg·kg⁻¹·min⁻¹) and flecainide (0.13 mg·kg⁻¹·min⁻¹) did not significantly inhibit AF inducibility and minimally affected atrial ERP. Flecainide decreased atrial conduction velocity, whereas NTC-801 and dofetilide did not. NTC-801 (0.1 mg/kg) converted AF to normal sinus rhythm. In summary, NTC-801 exerted more effective antiarrhythmic effects than dofetilide and flecainide in a canine LA-tachypacing AF model. The antiarrhythmic activity of NTC-801 was probably due to prolonging atrial ERP independently of stimulation frequency. These results suggest that NTC-801 could prevent AF more effectively in the setting of atrial electrical remodeling.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2013) studied Atrial fibrillation (canine model). NTC-801 vs. Dofetilide and flecainide was evaluated on AF inducibility, atrial effective refractory period (ERP), and atrial conduction velocity. NTC-801 dose-dependently decreased AF inducibility and prolonged atrial ERP more effectively than dofetilide and flecainide in a canine model of atrial tachypacing.
Synapse has enriched 10 related papers. Consider them for comparative context: